GovBidAlerts
← All opportunities
This notice has been superseded. See the latest notice: Sertraline HCL Tablets (Award Notice)

Sertraline HCL Tablets

Key dates

Posted
Jun 28, 2021
Response deadline
—
Archive date
Jun 27, 2026
Archive type
autocustom

Classification

Notice type
Award Notice
Base type
Solicitation
Set-aside
—
Set-aside code
—
PSC
6505

NAICS

  • 325412Pharmaceutical Preparation Manufacturing

    This U.S. industry comprises establishments primarily engaged in manufacturing in-vivo diagnostic substances and pharmaceutical preparations (except biological) intended for internal and external consumption in dose forms, such as ampoules, tablets, capsules, vials, ointments, powders, solutions, and suspensions. Cross-References. Establishments primarily engaged in--

Issuing office

Department
DEPT OF DEFENSE
Sub-tier
DEFENSE LOGISTICS AGENCY
Office
DLA TROOP SUPPORT
Office code
—
Organization type
OFFICE
Office address
PHILADELPHIA, PA, 19111, USA

Place of performance

Street
—
Street 2
—
City
Hauppauge
State
NY
Zip
11788
Country
USA

Contacts

Description

Sertraline HCL Tablets 25MG in 30, 90, 180 and 500 Count bottles, Sertraline HCL Tablets in 50MG in 30, 90, 180, and 500 Count bottles and Sertraline HCL Tablets in 30, 60, 90, 180 and 500 Count bottlles.

Award

Number
SPE2D221D0135
Amount
$24,078,212.33
Date
Jun 28, 2021
Awardee
Exelan Pharmaceuticals Inc. Boca Raton FL USA
UEI
—
Awardee address
—

Other notices in this solicitation

Similar open contracts

Similar past awards

Metadata

Notice ID
d8e11e617fa547e0898f70d6165d6077
Full path
DEPT OF DEFENSE.DEFENSE LOGISTICS AGENCY.DLA TROOP SUPPORT
Office code
—
Ingested
May 2, 2026
Updated
May 2, 2026
Raw record
{
  "CGAC": "097",
  "City": "PHILADELPHIA",
  "Link": "https://sam.gov/workspace/contract/opp/d8e11e617fa547e0898f70d6165d6077/view",
  "Sol#": "SPE2D220R0067",
  "Type": "Award Notice",
  "State": "PA",
  "Title": "Sertraline HCL Tablets",
  "Active": "Yes",
  "Award$": "24078212.33",
  "Office": "DLA TROOP SUPPORT",
  "PopZip": "11788",
  "Awardee": "Exelan Pharmaceuticals Inc. Boca Raton FL USA",
  "PopCity": "Hauppauge",
  "ZipCode": "19111",
  "AAC Code": "SPE2D2",
  "BaseType": "Solicitation",
  "NoticeId": "d8e11e617fa547e0898f70d6165d6077",
  "PopState": "NY",
  "SetASide": "",
  "Sub-Tier": "DEFENSE LOGISTICS AGENCY",
  "AwardDate": "2021-06-28",
  "FPDS Code": "97AS",
  "NaicsCode": "325412",
  "PopCountry": "USA",
  "PostedDate": "2021-06-28 12:36:58.31-04",
  "ArchiveDate": "2026-06-27",
  "ArchiveType": "autocustom",
  "AwardNumber": "SPE2D221D0135",
  "CountryCode": "USA",
  "Description": "Sertraline HCL Tablets 25MG in 30, 90, 180 and 500 Count bottles, Sertraline HCL Tablets in 50MG in 30, 90, 180, and 500 Count bottles and Sertraline HCL Tablets in 30, 60, 90, 180 and 500 Count bottlles.",
  "SetASideCode": "",
  "OrganizationType": "OFFICE",
  "PopStreetAddress": "",
  "ResponseDeadLine": "",
  "PrimaryContactFax": "",
  "AdditionalInfoLink": "",
  "ClassificationCode": "6505",
  "PrimaryContactEmail": "Phyllis.Daraio@dla.mil",
  "PrimaryContactPhone": "2157377941",
  "PrimaryContactTitle": "",
  "SecondaryContactFax": "",
  "Department/Ind.Agency": "DEPT OF DEFENSE",
  "SecondaryContactEmail": "",
  "SecondaryContactPhone": "",
  "SecondaryContactTitle": "",
  "PrimaryContactFullname": "Phyllis Daraio",
  "SecondaryContactFullname": ""
}